Signet Investment Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.64M Buy
30,517
+1,309
+4% +$125K 1.21% 32
2025
Q4
$2.81M Buy
29,208
+2,516
+9% +$244K 1.3% 33
2025
Q3
$2.54M Buy
26,692
+1,895
+8% +$174K 1.22% 34
2025
Q2
$2.16M Buy
24,797
+435
+2% +$36.9K 1.11% 34
2025
Q1
$2.19M Buy
24,362
+2,385
+11% +$213K 1.1% 37
2024
Q4
$1.76M Buy
21,977
+600
+3% +$51.9K 0.9% 40
2024
Q3
$1.92M Buy
21,377
+810
+4% +$68.1K 0.96% 41
2024
Q2
$1.62M Buy
20,567
+1,353
+7% +$111K 0.87% 44
2024
Q1
$1.67M Sell
19,214
-486
-2% -$41.5K 0.92% 43
2023
Q4
$1.62M Buy
19,700
+416
+2% +$31.7K 0.98% 41
2023
Q3
$1.51M Buy
19,284
+737
+4% +$61.7K 1% 41
2023
Q2
$1.63M Buy
18,547
+1,072
+6% +$92.3K 1.08% 37
2023
Q1
$1.41M Buy
17,475
+750
+4% +$61.1K 0.97% 40
2022
Q4
$1.3M Buy
16,725
+322
+2% +$26.1K 0.92% 42
2022
Q3
$1.32M Buy
16,403
+1,156
+8% +$104K 1.03% 39
2022
Q2
$1.37M Buy
15,247
+418
+3% +$42.4K 0.95% 42
2022
Q1
$1.65M Buy
14,829
+372
+3% +$39.3K 0.99% 40
2021
Q4
$1.5M Buy
14,457
+4,406
+44% +$510K 0.85% 40
2021
Q3
$1.26M Buy
10,051
+1,822
+22% +$236K 0.79% 44
2021
Q2
$1.02M Buy
8,229
+3,728
+83% +$468K 0.66% 49
2021
Q1
$532K Buy
4,501
+688
+18% +$80.6K 0.41% 60
2020
Q4
$447K Buy
+3,813
New +$420K 0.35% 57

Other funds holding MDT

Signet Investment Advisory Group's MDT Position: Q1 2026 in Review

Signet Investment Advisory Group increased its Medtronic (MDT) stake by 4.5% in Q1 2026, buying an estimated $125K and bringing the position to 30,517 shares worth $2.64M. The position accounts for 1.21% of the portfolio, ranked #32.

Signet Investment Advisory Group first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.81M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Signet Investment Advisory Group held 30,517 shares of Medtronic worth $2.64M as of Q1 2026.
  • Signet Investment Advisory Group bought 1,309 Medtronic shares in Q1 2026, an estimated $125K.
  • Medtronic made up 1.21% of Signet Investment Advisory Group's portfolio in Q1 2026, its #32 holding.
  • Signet Investment Advisory Group first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
  • Signet Investment Advisory Group's Medtronic position peaked at $2.81M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Signet Investment Advisory Group's 13F filing for Q1 2026, filed 14 May 2026.